Chimerix reported -23447000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Ardelyx ARDX:US $ -26.22M 1.59M
Chimerix CMRX:US -23447000 1.32M
Curis CRIS:US $ -15.06M 0.07M
Dynavax Technologies DVAX:US $ 128.23M 97.46M
Emergent Biosolutions EBS:US $ -72M 78.4M
Epizyme EPZM:US $ -29806000 21.12M
Gilead Sciences GILD:US $ 2029M 1832M
Glaxosmithkline GSK:US $ 1081M 1720M
Life Technologies LIFE:US $ -12.58M 0.21M
Merk MRK:US $ 4927M 642M
Mirati Therapeutics MRTX:US $ -177.2M 7.01M
Novavax NVAX:US $ -482.96M 692.25M
Xoma XOMA:US $ -4767000 2.7M